Ultrafiltration Techniques for Heart Failure Management

Ultrafiltration offers a mechanical approach to decongestion in heart failure by directly removing isotonic plasma water and sodium. This technique bypasses many of the limitations of pharmacological diuresis, particularly in patients with diuretic resistance or refractory congestion. Two principal modalities have been applied: veno-venous ultrafiltration, typically performed via specialised haemofilters in an extracorporeal circuit, and peritoneal ultrafiltration, which exploits the peritoneal membrane as a semi-permeable barrier. Both approaches aim to achieve controlled volume removal, reduce intracardiac pressures and improve organ perfusion without exacerbating renal dysfunction. Recent advances include simplified pump-driven devices for intensive care units, optimised ultrafiltration protocols to maintain haemodynamic stability and integration within a multidisciplinary care pathway. Globally, ultrafiltration is emerging as a complementary strategy for patients who remain congested despite maximal medical therapy, with demonstrated benefits in symptom relief, exercise capacity and reductions in hospital readmissions.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Research from all publishers

Meta-analyses of randomised and observational trials indicate that ultrafiltration achieves superior fluid removal and weight loss compared with standard diuretic regimens in acute decompensated heart failure. These analyses report a marked reduction in rehospitalisation rates and worsening heart failure events without a significant increase in renal impairment or all-cause mortality. A prospective, randomised clinical trial of early veno-venous ultrafiltration showed that initiating ultrafiltration within 24 hours of hospital admission led to greater net fluid loss, enhanced urine output and more pronounced reductions in natriuretic peptides than combination diuretic therapy, alongside improvements in functional class and jugular venous pressure while maintaining a stable renal profile. Peritoneal ultrafiltration has been evaluated in chronic refractory heart failure, with studies demonstrating sustained improvements in New York Heart Association functional class, decreased hospital days and enhanced quality of life over extended follow-up. These findings underscore the role of patient selection and timing of initiation, highlighting peritoneal ultrafiltration as a feasible long-term adjunct in those unsuitable for transplantation or advanced therapies.

Ultrafiltration Techniques for Heart Failure Management publication trend

The graph below shows the total number of articles in ultrafiltration techniques for heart failure management across all publications each year (not limited to Nature Index journals).

Technical terms

Ultrafiltration: Mechanical removal of isotonic fluid and solutes across a semi-permeable membrane under transmembrane pressure.

Acute decompensated heart failure (ADHF): Sudden worsening of heart failure symptoms requiring urgent medical intervention.

Diuretic resistance: Diminished natriuretic and diuretic response to loop diuretics despite escalated dosing.

Peritoneal ultrafiltration: Use of the peritoneal membrane to remove fluid via osmotic and hydrostatic gradients in long-term management.

New York Heart Association (NYHA) functional class: A four-tier system describing severity of heart failure symptoms during physical activity.

B-type natriuretic peptide (BNP): A cardiac hormone released in response to ventricular stretch, used as a biomarker of volume overload.

References

1. Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial. BMC Cardiovascular Disorders (2020).
2. Ultrafiltration is better than diuretic therapy for volume-overloaded acute heart failure patients: a meta-analysis. Heart Failure Reviews (2020).
3. Patients with high-dose diuretics should get ultrafiltration in the management of decompensated heart failure: a meta-analysis. Heart Failure Reviews (2019).
4. Peritoneal Ultrafiltration in the Long-Term Treatment of Chronic Heart Failure Refractory to Pharmacological Therapy. Frontiers in Physiology (2019).
5. Effectiveness and Safety of Peritoneal Dialysis Treatment in Patients with Refractory Congestive Heart Failure due to Chronic Cardiorenal Syndrome. BioMed Research International (2018).